EMA Authorised: Alkindi (hydrocortisone) — Immedica Netherlands B.V.

View source ↗

Summary

The EMA authorised Alkindi (hydrocortisone) by Immedica Netherlands B.V. for adrenal insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency

Drugs mentioned

• Alkindi (hydrocortisone)

Snippet

Status: Authorised. Therapeutic area: Adrenal Insufficiency. MAH: Immedica Netherlands B.V.. Decision date: 10/03/2026